In the BioHarmony Drug Report Database

"Preview" Icon

Radium ra-223

Xofigo (radium ra-223) is a small molecule pharmaceutical. Radium ra-223 was first approved as Xofigo on 2013-05-15. Xofigo’s patent is valid until 2022-11-17 (FDA).

 

Trade Name

 

Xofigo
 

Common Name

 

radium ra-223
 

ChEMBL ID

 

CHEMBL4297420
 

Indication

 

 

Drug Class

 

Quaternary ammonium derivatives

Image (chem structure or protein)

Radium ra-223 structure rendering